Author

Eric Yu

Primary ORCID profile (0000-0003-3525-4564 · 23 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Eric YuiD23 papers · Montreal Neurological Institute and Hospital

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Chenna Kesavulu SugaliiD· 1 shared Devon Hori HarveyiD· 1 shared Jiannong DaiiD· 1 shared Joseph Martin DallouliD· 1 shared Kamesh DhamodaraniD· 1 shared Michael PengiD· 1 shared Naga Pradeep RayanaiD· 1 shared Shaohui LiuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

9 top collaborators · 36 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Chenna Kesavulu SugaliORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of pterygium cell fibrosis by the Rho kinase inhibitor

Jiannong Dai, Naga Pradeep Rayana, Michael Peng, Chenna Kesavulu Sugali, Devon Hori Harvey, Kamesh Dhamodaran, Eric Yu, Joseph Martin Dalloul, Shaohui Liu, Weiming Mao

This study investigates the effect of a Rho kinase inhibitor on pterygium cell fibrosis, finding it reduces cell viability, migration, and extracellular matrix markers.

Scientific Reports · Dec 28, 2024Peer-reviewedPharmacology & Toxicology